In 2021, global sales of insulin pumps and related items were estimated at nearly $3.5bn. Market drivers include technological advancements such as the development of easy-to-wear pod-based designs and predictive software, the expanding use of insulin pumps as an alternative to syringe-based insulin delivery, an ever-increasing population of individuals requiring insulin drug delivery, and a significant disposables aftermarket. Market limiters include restrained healthcare spending in some countries due to slowed economic growth and a high per-unit cost for insulin pumps. Additionally, supply chain disruptions due to the Russian invasion of Ukraine, and a shortage of shipping containers have constrained growth. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for automated insulin pumps and related accessories.
Countries covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World. The forecast range for this report is 2021-26.
Table of Contents
Executive Summary
- Diabetes overview
- Market Overview
- Methodology
Chapter 1: Diabetes Overview
1.1 Variants of diabetes
1.2 Prevalence and incidence
1.3 Symptoms and complications
1.4 Diagnosis and treatment
1.5 Bibliography
Chapter 2: Automated Insulin Pumps Chapter 2
2.1 Insulin pump systems
2.2 The current state of insulin pump technology
2.3 Developments in insulin pump technology
2.4 Bibliography
Chapter 3: Market Analysis
3.1 Global market insights
3.2 Global competitors
3.3 Market forecast
3.4 Bibliography
Appendix: Company Listing
